What We Do
Psy Therapeutics developed a robust and innovative pipeline of high-potential central nervous system (CNS) therapeutics that focuses on anxiety, depression and dementia. We use a flexible approach to increase R&D productivity by applying validated cutting-edge technologies and forming strategic collaborations to advance our research programs.
The Pipeline
Primarily focused on Anxiety Disorders, Major Depressive Disorder and Dementia, our selection and pursuit of pipeline targets has been driven by novel insights from our world-leading scientists and clinicians and experienced neuroscience research executives from major biopharmaceutical companies.
See Our PipelineThe Need
The medical needs are significant and the opportunities to meaningfully improve the quality of care are vast. Anxiety Disorders, Major Depressive Disorder and Dementia affect more than 61 million people in the United States alone. We are inspired and driven to discover and develop new therapies to transform people’s lives.
Learn More
The Team
Our team of seasoned and accomplished professionals from world-leading biopharmaceutical companies, hospitals and academic institutions combines expertise in neuropsychiatry and business-building to create new futures for people affected by CNS disorders.
David S. Barlow
Chair & CEO
Bill Carlezon, PhD
SAB Member
Alan Cross, PhD
CSO & Chair, SAB
Maurizio Fava, MD
Co-Founder, SAB Member
Our Partners
Our strategic partners and collaborators are essential to our mission-driven success. They expand our scientific capabilities and allow a more flexible model for enhancing R&D productivity. Together, we are driven to discover, develop and deliver improved therapeutics to those in need.
Contact Us
To learn more about our capabilities, collaborators and investor opportunities, visit our contact page.
Get in Touch
Psy Therapeutics is on the cutting edge of developing novel drugs for CNS conditions, and Reaction Biology Corporation is happy to be part of your successful stories.We see the significant progress of your projects in a very short time and look forward to working more with your team collaboratively
Psy Therapeutics has established a world-class team to discover novel psychiatric medicines, alongside working with X-Chem’s highly successful drug discovery capabilities. Together, we have developed a highly productive collaboration to tackle novel, innovative targets.